A gene that is known to affect stress has been linked to the development of autism with exposure to stress in pregnant women.

‘The stress-sensitive gene known as 5-HTTLPR regulates the neurotransmitter serotonin in the nervous system. In pregnant women, the gene alters serotonin level, causing an increased reaction to stress.’

Led by Beversdorf’s graduate student, Patrick Hecht, Ph.D., in collaboration with Xudong Liu, Ph.D., with Queen's University in Ontario, Canada, the researchers studied two separate groups of mothers of children with autism spectrum disorder - a group of families at MU and a group of families at Queen's University. The mothers were surveyed about stress during their pregnancy, such as loss of a job, moving or divorce. The mothers'' blood was tested for a variation of the stress-sensitive gene known as 5-HTTLPR, which regulates the neurotransmitter serotonin in the nervous system. When a variation of the gene is present, the availability of serotonin is altered, causing an increased reaction to stress. 




In both groups, mothers of children with autism who have the variation of the stress-sensitive gene reported experiencing more stress during the end of the second and the beginning of the third trimester of pregnancy, compared to mothers who did not carry the altered gene.
"Though this was an observational study and future confirmation of this finding is needed, it's possible we could, one day, identify women who may be at a greater risk of having a child with autism when exposed to stress," said Beversdorf, who also serves as the William and Nancy Thompson Endowed Chair in Radiology. "More research is needed to understand the mechanisms of how this gene-stress interaction works, but hopefully, this could someday help prevent some cases of autism."
The study, "Maternal Serotonin Transporter Genotype Affects Risk for ASD with Exposure to Prenatal Stress," recently was published by Autism Research, the journal of the International Society for Autism Research. Research reported in this publication was supported by Mizzou Advantage, the MU College of Medicine Mission Enhancement Fund and the Ongwanada Fund. The researchers have no conflicts of interest to declare related to this study.
In addition to Beversdorf, Liu and Hecht, the research team included Melissa Hudson with Queen's University; Susan Connors, M.D., with Massachusetts General Hospital for Children; and Michael Tilley, Ph.D., with Central Methodist University.
Advertisement
Source-Newswise